REQUEST A DEMO
Total
USD $0.00
Search more companies

Savant Pharm S.A. (Argentina)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Savant Pharm S.A. Profile Updated: September 13, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English & Spanish Download a sample report

Savant Pharm S.A.manufactures and sells pharmaceutical products for prevention, alleviation, and cure of diseases in Argentina. It offers products in the form of solid, including tablets, coated tablets, and capsules; semi-solids, such as soft capsules and granules; and liquids comprising syrups and suspensions.

Headquarters
Ruta 19 Km 204
El Tio; Córdoba; Postal Code: X5000

Contact Details: Purchase the Savant Pharm S.A. report to view the information.

Website: http://www.savant.com.ar

Basic Information
Total Employees:
Purchase the Savant Pharm S.A. report to view the information.
Outstanding Shares:
Purchase the Savant Pharm S.A. report to view the information.
Financial Auditors:
Purchase the Savant Pharm S.A. report to view the information.
Ratings:
Purchase the Savant Pharm S.A. report to view the information.
Incorporation Date:
February 20, 2004
Key Executives
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Administrative Manager
Purchase this report to view the information.
Financial Manager
Purchase this report to view the information.
Manager of Human Resources
Purchase this report to view the information.
Marketing Manager
Ownership Details
Subsidiaries
Company Performance
Financial values in the chart are available after Savant Pharm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency ARS. Absolute financial data is included in the purchased report.
Net sales revenue
85.36%
Total operating revenue
85.32%
Operating profit (EBIT)
-39.24%
Net Profit (Loss) for the Period
N/A
Total assets
99.33%
Total equity
70.59%
Operating Profit Margin (ROS)
-9.32%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
51.74%
Quick Ratio
-0.14%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?